Pathophysiology of schizophrenia and the striatum.
D000328:Adult; D000661:Amphetamine; D000818:Animals; D001479:Basal Ganglia / Q000187:drug effects / Q000378:metabolism / Q000503:physiopathology*; D002375:Catalepsy / Q000139:chemically induced; D002421:Caudate Nucleus / Q000503:physiopathology; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004298:Dopamine / Q000096:biosynthesis / Q000502:physiology; D006168:Guinea Pigs; D006801:Humans; D006816:Huntington Disease / Q000503:physiopathology; D008954:Models, Biological; D008959:Models, Neurological; D009474:Neurons / Q000502:physiology; D010302:Parkinson Disease, Secondary / Q000139:chemically induced; D011955:Receptors, Drug / Q000187:drug effects; D012559:Schizophrenia / Q000139:chemically induced / Q000188:drug therapy / Q000503:physiopathology*; D013239:Stereotyped Behavior; D019966:Substance-Related Disorders; D014149:Tranquilizing Agents / Q000494:pharmacology
D011955:Receptors, Drug; D014149:Tranquilizing Agents; D004295:Dihydroxyphenylalanine; D000661:Amphetamine; D004298:Dopamine